Australia, Jan. 4 -- Australian Clinical Labs Ltd. (ACL) has reported gross short sales of 20,687 FPO shares on Jan. 2. The percent of issued capital of the company reported as short sales is 0.01 percent. The issued capital of the company is 200,575,839 shares.
Disclaimer: Curated by HT Syndication.
